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http://www.biomedcentral.com/1471-2164/15/833RESEARCH ARTICLE Open AccessQuantitative trait loci mapping for canine hip
dysplasia and its related traits in UK Labrador
Retrievers
Enrique Sánchez-Molano1, John A Woolliams1, Ricardo Pong-Wong1, Dylan N Clements2, Sarah C Blott3,4
and Pamela Wiener1*Abstract
Background: Canine hip dysplasia (CHD) is characterised by a malformation of the hip joint, leading to osteoarthritis
and lameness. Current breeding schemes against CHD have resulted in measurable but moderate responses. The
application of marker-assisted selection, incorporating specific markers associated with the disease, or genomic
selection, incorporating genome-wide markers, has the potential to dramatically improve results of breeding
schemes. Our aims were to identify regions associated with hip dysplasia or its related traits using genome and
chromosome-wide analysis, study the linkage disequilibrium (LD) in these regions and provide plausible gene
candidates. This study is focused on the UK Labrador Retriever population, which has a high prevalence of the disease
and participates in a recording program led by the British Veterinary Association (BVA) and The Kennel Club (KC).
Results: Two genome-wide and several chromosome-wide QTLs affecting CHD and its related traits were identified,
indicating regions related to hip dysplasia.
Conclusion: Consistent with previous studies, the genetic architecture of CHD appears to be based on many genes
with small or moderate effect, suggesting that genomic selection rather than marker-assisted selection may be an
appropriate strategy for reducing this disease.
Keywords: Canine hip dysplasia, Labrador Retriever, Norberg Angle, QTL, GWAS, Genomic selectionBackground
Canine hip dysplasia (CHD) is a pathology characterised
by the malformation of the coxo-femoral joint, leading to
degeneration of the hip joint, lameness and painful osteo-
arthritis. It mainly affects large-sized breeds like the
German Shepherd and Labrador Retriever and has an
important impact due to its high prevalence in these
breeds (25-40% in UK Labrador Retrievers [1], depend-
ing on the study). The disorder is a major health
concern of dog owners, breeders and organizations (e.g.
the American Kennel Club [2]) and cannot be cured, al-
though it can be ameliorated by surgery and there is
some suggestion that modification of certain factors
(e.g. reduction of dietary calcium and vitamin D in* Correspondence: pam.wiener@roslin.ed.ac.uk
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University
of Edinburgh, Easter Bush, Midlothian EH25 9RG, Scotland, UK
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article, unless otherwise stated.growing dogs, [3]) may improve the condition. Al-
though surgical/medical treatment can be used to im-
prove the quality of life of the dog, it has been shown
that CHD has a moderately heritable genetic basis [4]
and due to the difficulty of treating the disease, a gen-
etic solution should be explored.
A genetic strategy relies on selecting breeding individ-
uals on the basis of their predicted breeding value, with
greater accuracy of prediction offering faster progress.
To date these predictions have relied on mass selection
on a phenotype measured at a young age, and often
prior to the onset of clinical disease. In many countries,
this phenotype is based on a radiographic analysis of the
pelvic area, and in the UK this scheme is run jointly by
the British Veterinary Association (BVA) and The Kennel
Club (KC) [5]. In this scheme, animals older than one year
of age are scanned, when skeletal maturity is assumed to
have been achieved (although no upper age limit isd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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calculated as the sum of nine component traits mea-
sured on categorical scales on both hips. Thus, hips
with a perfect radiographic appearance will have a HS
of 0, and the higher the score (up to 106), the greater
the degree of CHD and/or degenerative change. Three
of these component traits (Norberg Angle, Subluxation
and Cranial Acetabular Edge) are measures of joint
laxity. The other six are related to osteoarthritis which
develops as a result of joint laxity, and therefore are
more subject to detrimental age effects [6]. Lewis et al.
[6] also observed that the measures of laxity were more
heritable than those associated with osteoarthritis.
Current breeding programmes against the disease are
voluntary and recommend breeding from animals with
HS (or equivalent) below a given threshold. They have
resulted in measurable but moderate success [7-10]. Ap-
proaches that could enhance the performance of these
programmes include selection based on phenotype-
derived estimated breeding values (EBVs) [9-11] and/or
marker-assisted or genomic selection [12,13], where
specific markers associated with the disease or genome-
wide markers, respectively, are incorporated into breed-
ing values. Previous studies regarding CHD, based on
sample sizes of 150-800 animals and using microsatel-
lites [14,15] or SNPs [16-19], have shown inconsistent
results for QTL position depending on the breeds, dens-
ity of markers, allele frequencies and statistical methods
used. These studies, usually focused on Norberg Angle
or an equivalent measure to HS, have shown no evi-
dence of a major locus controlling CHD, suggesting a
complex disease driven by a number of QTL with small
or moderate effect [17]. Although a few positional candi-
date genes have been proposed [19], only one study has
demonstrated a putative association between mutations
in a specific gene (fibrillin 2 gene) and the disease [20].
The purpose of this study was to perform genome-
and chromosome-wide scans to identify QTLs for hip
score and the three components associated with laxity in
Labrador Retrievers, with the aims of improving selec-
tion schemes against the disease and furthering under-
standing of the biological basis of CHD.
Methods
Animals and phenotypes
The genotyped sample comprised 1500 hip-scored
Labrador Retrievers born between 2002 and 2008, which
provides a representative sample of animals used for
breeding. Dogs were evaluated for hip dysplasia based
on radiographs according to the UK scoring method, re-
cording the nine hip score components for each separate
hip [5]. These components are the following: Norberg
Angle (NA), Subluxation (SUB), Cranial Acetabular Edge
(CrAE), Dorsal Acetabular Edge (DAE), Cranial EffectiveAcetabular Rim (CrEAR), Acetabular Fossa (AF), Caudal
Acetabular Edge (CAE), Femoral Head and Neck Exo-
stosis (FHNE) and Femoral Head Recontouring (FHR).
Owners of animals with hip scores and aged between 1
to 6 years old were contacted and requested to provide
buccal DNA swabs and to fill in a questionnaire with de-
tails of body measurements (length, weight, girth and
body conformation), exercise levels, lifestyle and nutri-
tion, activity and concurrent health problems. Traits in-
corporated in statistical models are described below.
Animal ethics
Radiographs were taken by veterinarians for submission to
the British Veterinary Association/Kennel Club hip and
elbow scoring schemes, a health screening protocol required
before breeding from Kennel Club registered Labrador Re-
trievers. Hip and elbow score results are available to the
public from the Kennel Club (https://www.thekennelclub.
org.uk/services/public/mateselect/test/Default.aspx.).
Owners collected saliva samples themselves by using
non-invasive buccal swabs after being provided with de-
tailed instructions and an explanatory video. The sample
was collected at home. This sampling strategy was chosen
instead of involving a journey to a vet practice and collec-
tion by a veterinarian as this was deemed less stressful for
the dog and of negligible risk. Advice obtained from
personnel responsible for the ethical review process in
The Roslin Institute (University of Edinburgh) was that no
ethical approval was needed under the Animal Scientific
Procedures Act (1986) because the technique was quick,
non-invasive and painless and therefore was not a regu-
lated procedure. The internal review process at the Insti-
tute also approved the research plan.
DNA extraction and SNP genotyping
Extraction of DNA from buccal swabs was performed ac-
cording to a standard protocol [21]. DNA was re-
suspended in water and quantified using a Nanodrop
and stored at 4°C until use. Animals were genotyped
using the Illumina Canine High Density Beadchip con-
taining 173,662 SNPs [22].
Quality control procedures
Quality control was performed to assure both sample
quality and marker quality [23]. A sample call rate thresh-
old of 90% was applied, removing 275 samples with a low
call rate. A further 27 animals were removed due to po-
tential genotyping errors, detected as inconsistencies
between the genomic and pedigree relatedness of individ-
uals or between recorded sex and sex determined from the
genotyping. The analysis of the age at scoring (Figure 1)
showed a detrimental age effect on the hip score in animals
older than 5 years. In order to remove this age-related bias,
animals older than 5 years when scored (total of 19) were
Figure 1 Effect of the age at scoring on transformed hip score
(THS). The red trend line corresponds to a quadratic Loess regression.
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size of 1179 animals.
Filtering criteria were applied to markers using Genome
Studio software. A total of 59,260 markers were discarded
due to low call rate (<98%), low reproducibility (GTS < 0.6),
low or confounded signal (ABR mean < 0.3) and low minor
allele frequency (MAF < 0.01). Further quality control on
the markers was applied using PLINK [24], removing SNPs
on the sex chromosomes and those showing deviation from
Hardy-Weinberg equilibrium (threshold of 4.48E-7 apply-
ing a Bonferroni correction), finally resulting in 106,282
SNPs for further analysis, with their positions assigned ac-
cording to the CanFam 2.0 assembly.
Population structure
Preliminary analyses of population attributes (working
status, coat colour) did not show associations with hip
score, therefore, the genomic relationship matrix was fit-
ted (as explained below) and was assumed to account
for any remaining population structure.
Genome-wide association analysis (GWAS)
Association analyses were performed for total hip score
(HS), transformed total hip score (THS, logarithmic
transformation, ln(1 + HS), following Lewis et al. [3])
and for the main three components on both hip sides
(left, right and total): Norberg angle (NA), Subluxation
(SUB) and Cranial Acetabular Edge (CrAE), using a lin-
ear mixed model as follows:
y¼Wαþxβþuþε
where y is the vector of phenotypes, W is a matrix of
covariates with the α vector of associated fixed effects(including the intercept), x is a vector of marker geno-
types (coded as 0/1/2) with β representing the regres-
sion of the phenotype on the marker genotypes, u is a
vector of random polygenic effects and ε is a vector of
residual errors. The fixed factors considered were the
following: gender (1 degree of freedom), age at scoring
in years and time spent exercising per day, which was
scored from 1 (up to 1 hour) to 4 (more than 4 hours).
The latter two factors were fitted as linear and quad-
ratic regressions on deviations from their means.
Analyses were conducted using GEMMA [25], which
accounts for population stratification by including the
genomic relatedness matrix (GRM, G) [26], and assum-
ing a model where the vectors of random effects, u,
and errors, ε, follow multivariate normal (MVN) distri-
butions given by u ~MVN(0,VGG) and ε ~MVN(0,VEI),
where VG and VE are the genetic variance associated
with G and environmental variance, respectively.
GEMMA provides regression coefficient for each
marker and their statistical significance was assessed
using a Wald test. In determining a genome-wide sig-
nificance threshold of P < 0.05, a conservative Bonfer-
roni correction was made for multiple testing resulting
from the large number of markers but not for multiple
traits, resulting in a final threshold of P < 4.705E-7.
The group of traits considered all share high pairwise
genetic correlations, in excess of 0.85 [4,6], and there-
fore the appropriate correction for multiple traits is
unclear.
Differences in allele frequencies that are artefacts of
cryptic population stratification or genotyping errors
may inflate test statistics (mean and median χ2 values)
above their expectations under the null hypothesis. This
inflation was detected and corrected by the use of the
inflation factor λ, defined as the ratio of the median of
the empirically observed distribution of the test statis-
tic to the expected median (thus quantifying the extent
of the inflation and the excess false positive rate), fol-
lowing the method suggested by Amin et al. [27], as-
suming that the inflation is roughly constant across
the genome.
Genomic, chromosomal and regional variances
An improved estimate of VG, the total genetic variance,
was obtained by removing the regression on marker
genotype from the GWAS model. Therefore, the follow-
ing mixed linear was fitted:
y¼Wαþuþε
where the meaning and distributional assumptions for
each of these terms were as described above for the
GWAS model. To compare the estimates of genetic
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the model was re-fitted with u ~MVN(0,VAA), where A
is the numerator relationship matrix derived from the
5- generation pedigree of the phenotyped dogs, and VA
is the associated additive genetic variance.
Using similar models the genetic variance was also par-
titioned among chromosomes using two different ap-
proaches: (1) a joint decomposition of the 38 canine
chromosomes involving the simultaneous fitting of 38
chromosome-specific GRMs, or (2) chromosome-specific
analyses in which the GRM for each chromosome was fit-
ted together with a complementary GRM constructed
from the all other SNPs to account for the remaining
polygenic effect. In the first approach, the model fitted
was of the form:
y¼WαþΣu ið Þþε
where y is the phenotype of each individual and, as in
previous models, W and α refer to the fixed effects de-
scribed above. In this approach (joint chromosomal de-
composition), each u(i) (i = 1, …, 38) represents a vector
of genetic values for chromosome i, such that u(i) ~
MVN(0,VC(i)G(i)) where G(i) is the GRM calculated from
only those SNPs on chromosome i, and VC(i) is the asso-
ciated variance. The estimate of total genetic variance is
Vc ¼
P38
i¼1VC ið Þ: In the second approach, the total gen-
etic variance was decomposed into a model with only
two components:
y¼Wαþu ið Þþu ‐ið Þþε
where u(i) is the effect of chromosome i, as described
above, and distributed as MVN(0,VC(i)G(i)) and u(‐i) is a
polygenic effect for the remaining genome and distrib-
uted as MVN(0,VC(-i)G(-i)) where G(-i) is a GRM con-
structed from all SNPs other than those on chromosome
i. Therefore in this second model, the model was fitted
38 times, once for each of the 38 chromosomes, with
analysis of chromosome i providing an estimate for VC(i).
Regional VG [28] for windows of 20 SNPs centred upon
the GWAS-significant SNPs were evaluated considering
the region plus a complementary polygenic effect. Re-
gional VG across the entire genome was also evaluated. In
the latter analysis, the genome was divided into distinct
regions, each containing 20 adjacent SNPs. The analysis
then proceeded similarly to the approach described above
for chromosomal variances with two components. Under
the first approach, the SNP windows were always centred
at the GWAS-significant SNPs, whereas under the second
one, the significant SNP was not necessarily at the centre
of a window.
The regional variances for significant SNPs and genomic
and chromosomal variances were estimated for each trait
using ACTA [29], but the full regional exploration with20-SNP windows was carried out using REACTA [30] for
computational ease.
An additional analysis of the haplotype structure and
linkage disequilibrium (LD) in the genome-wide signifi-
cant regions was performed using Haploview 4.2 [31].
Genome-wide significant regions were analysed for their
haplotype structure and LD, and investigated for func-
tional candidate genes showing strong LD with the sig-
nificant SNPs.
Results
Four SNPs with genome-wide significance (Table 1) and
73 SNPs with chromosome-wide significance (Additional
file 1) were detected in the GWAS analyses and Manhattan
plots for two of the traits are shown (Figures 2 and 3). The
genomic estimates of the residual (VE) and genetic (VG)
variances for each trait are shown in Table 2, together with
the pedigree-based estimates. Quantile-Quantile (Q-Q)
plots of GWAS analyses for all traits after correcting
by the inflation factor are shown in the supplementary
material (Additional file 2). The supplementary mater-
ial also contains the estimates of the genetic variances
(VC) at the chromosome level calculated using the two
different approaches described above: joint chromosomal
decomposition of the 38 chromosomes (Additional file 3)
and separate analyses of each chromosome with all other
chromosomes included as part of the polygenic effect
(Additional file 4). Additional file 5 shows both sets of re-
sults in a graphical form. Results for the chromosomal
analyses (Additional files 3 and 4) are presented as per-
centages of the total genetic variance explained by the
genomic estimates given in Table 2 and thus add up to 1.
The regional heritability analysis determined percentages
of genetic variance explained for each trait based on win-
dows of 20 SNPs across the genome (Additional file 6) or
only for the regions centered at the GWAS-significant
SNPs (Additional file 7).
Hip score (HS) and Transformed hip score (THS)
No SNPs with genome-wide significance were detected
for these traits (Table 1), although the application of
chromosome-wide thresholds (Additional file 1) identi-
fied several significant SNPs for both HS (on Chr 1, 2,
11, 15, 21 and 23) and THS (on Chr 11, 24 and 38).
Chr 9 and 11 clearly explained the highest proportions
of genetic variance obtained from the joint chromosomal
decomposition for HS (22.6% and 19.7% of the total VC).
In contrast, for THS, VC was more evenly distributed
across the genome, with Chr 1, 9, 21 and 24 explaining
the highest proportions of VC, 6.6%, 15.3%, 11% and
8.3%, respectively (Additional files 3, 4 and 5).
The estimates of the residual variance (VE) from gen-
omic analyses were greater (and heritability lower) than
their pedigree estimates (Table 2) for HS, indicating
Table 1 Summary of genome-wide significant SNPs using a linear mixed model for canine hip dysplasia in UK Labrador
retriever
CHR SNP Position Trait MA MAF Beta coef. P-value %VG
1 BICF2P219706 100106009 CrAE left G 0.019 0.52 ± 0.10 3.35E-07 22.2 ± 17.2
1 BICF2P219706 100106009 CrAE total G 0.019 0.94 ± 0.18 3.20E-07 13.5 ± 9.90
1 BICF2S2443186 100138261 CrAE left A 0.019 0.52 ± 0.10 3.34E-07 22.6 ± 17.7
1 BICF2S2443186 100138261 CrAE total A 0.019 0.94 ± 0.18 3.21E-07 13.8 ± 10.4
1 BICF2P1285984 107719908 CrAE left G 0.018 0.53 ± 0.10 1.97E-07 33.2 ± 19.5
1 BICF2P1285984 107719908 CrAE total G 0.018 0.97 ± 0.19 2.20E-07 20.6 ± 11.8
21 BICF2P429643 43337454 NA right G 0.222 0.40 ± 0.08 3.08E-07 13.1 ± 9.1
The table shows chromosome, significant SNPs, position (in base pairs according to CanFam 2.0), associated trait (total hip score (HS), transformed total hip score
(THS), Norberg Angle (NA), Subluxation (SUB) and Cranial Acetabular Edge (CrAE)), minor allele (MA) and its frequency (MAF), Beta coefficient (minor allele
substitution effect), P-value for the Beta coefficient from the GWAS analysis and percentage of genetic variance explained by a region of 21 SNPs centred at the
significant SNP.
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phenotypic variance and thus appeared not to capture
the full additive genetic variance. In contrast, for THS,
the estimates of VE were very similar. The regional her-
itability analyses (Additional file 6) showed several
peaks across the genome, and although no significant
regions were detected for HS, a significant region was
detected for THS on Chr 21 (41.4 Mb). This region was
not concordant with the chromosome-wide significant
SNP detected by GWAS for this trait (27.9 Mb) but
close to significant SNPs detected for other traits (NA
and CrAE) on this chromosome.
Norberg Angle (NA)
A SNP with genome-wide significance (Table 1 and
Figure 2) was detected for the right hip on Chr 21 and
several SNPs with chromosome-wide significance
(Additional file 1) were detected for the right hip (Chr
1, 10, 12, 13, 15, 21, 26, 27, 30 and 38), the left hipFigure 2 GWAS analysis for the Norberg Angle right. The genome-wid
nominal P-value = 0.05.(Chr 4, 14, 22, 23 and 25) and the total NA (Chr 12,
21, 23, 27 and 38).
For the right-hip NA, Chr 11 and 21 clearly explained
the highest proportions of genetic variance (21.7% and
16.9% of VC) whereas for the left-hip NA, the total VG
was more evenly distributed across the genome, with
several chromosomes explaining similar percentages. Re-
sults for total NA were a mixture of those for left and
right hips, with Chr 3, 4, 9, 11 and 21 explaining the
highest proportions of VC, 6.7%, 6.9%, 6.8%, 7.5% and
6.7%, respectively (Additional files 3, 4 and 5).
The estimates of residual variances (VE) from genomic
analyses for all three traits associated with NA were
greater (with lower heritability) than the pedigree esti-
mates (Table 2), again indicative that the GRM did not
capture the full genetic variance. Regional heritability
analyses showed several peaks across the genome, none
of which were significant (Additional file 6). The SNP on
Chr 21 detected by GWAS explained 13.1% of thee threshold (red line) corresponds to the Bonferroni correction for a
Figure 3 GWAS analysis for the CrAE total. The genome-wide threshold (red line) corresponds to the Bonferroni correction for a
nominal P-value = 0.05.
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high (Table 1).Subluxation (SUB)
No SNPs with genome-wide significance were detected,
although several SNPs with chromosome-wide signifi-
cance (Additional file 1) were detected for the right hip
(Chr 6, 22, 24, 31 and 38), the left hip (Chr 6, 20 and 36)
and total SUB (Chr 6, 24, 27 and 35).
For the right-hip SUB, Chr 1, 7, 9, 21 and 24 explained
the highest proportions of total genetic variance, 9.7%,
8.2%, 7.5%, 8.3% and 8.7% of the total VG, respectively,
whereas for the left-hip SUB, the highest proportions
were explained by Chr 9 and 24 (10% and 11%). In the
case of SUB total, Chr 1, 9 and 24 explained the highest
proportions, 7.2%, 7.2% and 7.3% of the total VG, re-
spectively (Additional files 3, 4 and 5).Table 2 Estimates of variance components
Trait Pedigree
h2 VG VE
HS 0.59 ± 0.13 73.13 ± 17.33 51.12 ±
THS 0.27 ± 0.11 0.11 ± 0.04 0.29 ±
NA right 0.29 ± 0.11 0.56 ± 0.22 1.41 ±
NA left 0.52 ± 0.12 1.10 ± 0.27 1.01 ±
NA total 0.44 ± 0.12 2.88 ± 0.81 3.65 ±
SUB right 0.28 ± 0.10 0.29 ± 0.10 0.77 ±
SUB left 0.23 ± 0.10 0.33 ± 0.12 0.78 ±
SUB total 0.36 ± 0.10 1.09 ± 0.33 1.95 ±
CrAE right 0.19 ± 0.10 0.08 ± 0.04 0.32 ±
CrAE left 0.06 ± 0.08 0.03 ± 0.04 0.41 ±
CrAE total 0.15 ± 0.10 0.21 ± 0.14 1.23 ±
The table shows the heritabilities (h2) and genomic (VG) and residual variances (VE)
score (HS), transformed total hip score (THS), Norberg angle (NA), Subluxation (SUBThe estimates of residual variances (VE) from genomic
analyses for all three traits were again slightly higher
(lower heritability) than the pedigree estimates (Table 2),
and regional heritability analyses showed several non-
significant peaks and one significant peak on Chr 9 for
left-hip SUB (16.5 Mb), which was not concordant with
SNPs detected for other traits (Additional file 6).Cranial Acetabular Edge (CrAE)
SNPs with genome-wide significance (Table 1 and Figure 3)
were detected on Chr 1 for the right and the left hips,
and several SNPs with chromosome-wide significance
(Additional file 1) were also detected for the right hip
(Chr 13 and 21), the left hip (Chr 12, 15 and 38) and
the total CrAE (Chr 12 and 38).
Unlike HS and traits associated with NA and SUB, the
genomic estimates of the residual variances (VE) for theGenomic
h2 VG VE
15.08 0.23 ± 0.06 27.42 ± 7.41 93.57 ± 7.22
0.04 0.25 ± 0.06 0.10 ± 0.02 0.29 ± 0.02
0.21 0.15 ± 0.05 0.30 ± 0.11 1.97 ± 0.08
0.24 0.36 ± 0.06 0.66 ± 0.14 1.43 ± 0.12
0.73 0.27 ± 0.06 1.74 ± 0.40 4.73 ± 0.38
0.10 0.21 ± 0.06 0.22 ± 0.06 0.84 ± 0.06
0.11 0.18 ± 0.06 0.20 ± 0.06 0.90 ± 0.07
0.31 0.28 ± 0.06 0.85 ± 0.19 2.19 ± 0.13
0.04 0.20 ± 0.06 0.08 ± 0.02 0.32 ± 0.02
0.04 0.11 ± 0.05 0.05 ± 0.02 0.40 ± 0.03
0.14 0.18 ± 0.06 0.26 ± 0.08 1.18 ± 0.09
estimated under the pedigree and genomic approaches for each trait (total hip
) and Cranial Acetabular Edge (CrAE)).
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pedigree estimates (Table 2). The regional heritability
analyses did not reveal any significant peaks across the
genome (Additional file 6). The SNPs detected by GWAS
on Chr 1 showing genome-wide significance explained
13.5-33.2% of the genetic variance (VG) but again the
standard errors were very high (Table 1).General observations across traits
Due to the Beavis effect, the estimates of effect sizes (Beta
coefficients) and the proportion of genetic variance ex-
plained by each chromosome or region, considered separ-
ately, are expected to be overestimates [32]. Therefore
the results obtained by the joint chromosomal decom-
position (fitting all the chromosomes simultaneously in
the same model) are expected to be more accurate than
the chromosomal variances obtained for each chromo-
some separately when compared with the total (GRM-
based) genetic variance. The similarity of our estimates
of VG and VC calculated from the joint chromosomal
decomposition (results not shown), support this predic-
tion and therefore, we subsequently focus on estimates
of individual chromosomal variance from the joint
chromosomal decomposition. These estimates revealed
a polygenic architecture for all traits, with several chro-
mosomes contributing less than 6% of the total genetic
variance and a few chromosomes contributing 15-23%.
All animals, including those with perfect hip scores
(HS = 0), were included in the analyses. However, Lewis
et al. [4] detected an excess of zero individual scores for
HS, based on non-linearity of the regression of offspring
phenotype onto mid-parent phenotype, suggesting a
lower precision of evaluation in the lower tail of the trait
distribution. To address this, parallel genome-wide
GWAS analyses were performed for all traits removing
all animals with a HS = 0. Results of these analyses (not
shown) were similar to the results shown previously for
the full sample of animals.Discussion
The present study used a high density canine chip to iden-
tify two genome-wide QTLs affecting CHD-related traits.
Chr 1 and 21 revealed consistent GWAS peaks and signifi-
cant SNPs across the analyses in relation to several traits.
Other suggestive QTLs were detected as significant at the
chromosome-wide level, and may also indicate genomic re-
gions related to hip dysplasia. In order to strengthen the
evidence for QTLs identified in our study, we have applied
two additional analyses: chromosomal and regional ana-
lyses of the explained genetic variance. These methods are
designed to estimate variances associated with multiple loci
contributing localised variance that may be too small indi-
vidually to detect by single association tests [28,33] and toestimate the variance explained by a QTL rather than its
allelic substitution effect.
Chr 1 explained ~23% and ~13% of the total VG ob-
served for CrAE left and CrAE total, respectively, and
revealed six genome-wide significant SNPs for these
traits, as well as chromosome-wide significant SNPs related
to HS and NA right. These SNPs were located between
two QTLs for CHD status in German Shepherds [16] and
within 10 Mb of a QTL for NA right in Portuguese Water
dogs [14]. Genes in the region between 99.00 Mb and
110.00 Mb on Chr 1, which encompasses all of the
genome- and chromosome-wide significant SNPs, were in-
vestigated. Two genome-wide significant SNPs were found
within the SHC3 gene, which is not known to be associated
with CHD-related traits, however, within 1 Mb of this gene,
there were several functional candidate genes, associated
with bone formation or mineralization (SEMA4D, OMD,
OGN), cartilage formation (PHF2), and differentiation into
joint versus cartilage cells (BARX1). However, none of the
SNPs within or closest to these genes showed high LD
(assessed by r2) with the SNPs identified by GWAS. The
third genome-wide significant SNP was found in an inter-
genic region, close to a zinc-finger gene (ZNF677), which
again is not known to have any association with CHD-
related traits, and several uncharacterised protein-coding
genes. The large size of the Chr 1 region, and hence the
large number of positional candidate genes, highlights a
problem in the identification of causative variants from
GWAS studies in species with high levels of LD such as
dogs.
While this 11-Mb region on Chr 1 included the greatest
number of genome-wide significant SNPs in our study,
the frequency of the favourable SNP alleles (associated
with low hip score) is already very high, suggesting that
the average effect of the favourable allele is small [34] and
consequently little genetic progress in CHD could be
made by changes in frequencies at this QTL. This assumes
that the allele frequency of the causal variant is similar to
the marker, which may not be the case. However, the r2
(and power of detection) between a marker and a causal
variant is sensitive to differences in allele frequency, par-
ticularly at low frequencies, suggesting that the allele fre-
quencies of the marker and causative variant cannot be
radically different.
Chr 21 explained ~17% of the total VG observed for
NA right, revealing one genome-wide significant SNP
for this trait, several chromosome-wide significant SNPs
related to NA, CrAE and HS and a significant peak in
the regional analysis for THS. These SNPs correspond to
two main regions: a genome-wide significant region situ-
ated at ~43 Mb and a chromosome-wide significant re-
gion situated at ~27 Mb. For the first case, previous
studies have shown the existence of a QTL related to
NA in this region for a Labrador-Greyhound cross-breed
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German Shepherds [16]. The genome-wide significant
SNP from our study is found within the OTOG gene,
which encodes an ear-specific glycoprotein that has no
known association with CHD-related traits. However, as
with the Chr 1 region, there are several functional candi-
date genes between 41.5 and 44.5 MB, the region that
includes the genome- and chromosome-wide significant
SNPs. These include genes associated with cartilage for-
mation (SOX6), inflammation and osteoarthritis (SAA)
and muscle cell differentiation and muscle regeneration
(MYOD1, SERGEF). Again, most of the SNPs within or
closest to these genes showed low LD with the SNPs
identified by GWAS, however, one SNP within SERGEF
was strongly correlated (r2 = 0.8) with the genome-
significant SNP and two SNPs within SOX6 were moder-
ately correlated with it (r2 = 0.4). In comparison to the
region on Chr 1, there is greater potential for genetic
progress based on this region as the frequency of the
favourable allele is much lower for this QTL.
Chromosome-wide QTLs were detected on several
chromosomes and a polygenic pattern was also observed
for the distribution of the genetic variance in both the re-
gional and chromosomal studies, with most of the chro-
mosomes explaining less than 6% of the genetic variance
but some chromosomes explaining between 10% and 23%.
These results confirm a polygenic nature of the disease
that could arise if the hip score and its components were
the result of multiple interacting processes. It might be
the case that genes affecting one or two processes have a
small effect on the main phenotype (resulting in many
QTLs with small effect), while only genes affecting several
processes appear as QTLs with larger effects. The com-
plex aetiology of the disease supports its polygenic nature.
Both biological and environmental factors potentially con-
tribute to an unstable hip joint [35] and many different
genes are likely to influence the biological factors (e.g.
bone and cartilage formation, muscle and other soft tissue
development, inflammatory responses), which when dis-
rupted, could contribute to disease. It is worth noting that
while identification of the genes associated with the major
QTLs detected in our study would contribute to an im-
proved understanding of the biology of CHD and may
help in the development of therapies, our results suggest
that these QTLs will not capture most of the genetic vari-
ance related to this disease.
Another aspect of the trait complexity found in our
study and several others [14,15,17,36] is that some QTL
effects are stronger on one side of the body than the other,
despite the fact that a high genetic correlation between
right and left scores has been observed in both Labrador
Retriever and German Shepherd breeds [4,37]. These find-
ings could result from asymmetrical dogs’ gaits (even with
normal hips) [38] or from suboptimal positioning of dogswhen scoring, but also could be a statistical artefact of
identification of QTL with small effects.
In order to further explore the QTLs identified in our
study, the performance of the SNP-based genomic ap-
proach to characterise the genetic architecture of the
trait was also compared with the pedigree approach in
terms of residual variance (VE). Residual variance was
used to compare the models because in both cases, it
comprises the variance component not explained by the
model for the phenotypes in the data, whereas, in con-
trast, the genetic variances obtained using genomic and
numerator (pedigree-based) relationship matrices refer
to constructed base populations, which may differ. SNP-
based methods are not expected to capture all the gen-
etic variance [33] and our results broadly confirm this
hypothesis, with our genomic estimates of VE greater
than those provided by a pedigree analysis for most of
the traits, but not in all cases. It is expected that an in-
crease in the number of markers will increase the pro-
portion of explained genetic variance [39,40].
Although some detected QTL regions (e.g. Chr 1 and
21) correspond with those found in previous QTL studies,
others have not been seen before and equally, we did not
detect effects in several previously identified regions. There
was no overlap between the regions showing genome- or
chromosome-wide significance and those associated with
CHD severity in a recent case-control study of 78 Dutch
Labrador Retrievers [41] (the closest SNPs detected in their
study, on Chr 25, were > 5Mb from a chromosome-wide
significant region in our study). This inconsistency of
QTLs across different studies has been previously pointed
out by Zhu et al. [17], and in addition to the possibility that
some results are false positives, might be explained by the
different selection pressures applied to each breed or popu-
lation, the varying LD patterns found in different breeds
[42,43], the specific details of the different studies (number
of animals, pedigree structure, marker type and density)
and the stochasticity associated with detecting small (but
real) effects across multiple regions. Some of these factors
probably also account for the limited consistency between
GWAS results for the highly correlated traits within this
study.
Conclusion
In summary, two genome-wide significant QTLs on Chr
1 and 21 and three chromosome-wide significant QTLs
on Chr 11, 21 and 24 were detected in a Labrador Re-
triever population, associated with hip score or its com-
ponents. However, none of the chromosomes explained
more than 23% of the genetic variance of the traits.
These findings, taken with the complex nature of the hip
score as the sum of different components, possibly re-
lated to different metabolic processes, suggests a gen-
etic architecture based on many genes with small or
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is not likely to be successful. Alternatively, a genomic
selection approach against the disease should be con-
sidered [44].
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Additional file 1: Summary of chromosome-wide significant SNPs
using a linear mixed model for canine hip dysplasia in UK Labrador
Retriever: The table shows chromosome, significant SNPs, position (in
base pairs according to CanFam 2.0), associated trait, minor allele and its
frequency, Beta coefficient (minor allele substitution effect), P-value of the
GWAS analysis and percentage of genetic variance explained by a region of
21 SNPs centred in the significant SNP.
Additional file 2: Quantile-Quantile plots for GWAS analyses. Figures
show the Q-Q plots after correcting by the inflation factor.
Additional file 3: Percentage of genetic variance explained per
chromosome: The joint chromosomal decomposition model fitted
the 38 chromosomes simultaneously. (Note: equivalent to the red bars
in Additional file 5). Percentages are related to the total genetic variance
explained by the genomic method (given in Table 2). The proportion of
the genome accounted for by each chromosome (PG) is also given.
Additional file 4: Percentage of genetic variance explained per
chromosome: The model considers a separate analysis of each
chromosome including a complementary GRM accounting for the
polygenic effect. (Note: equivalent to the blue bars in Additional file 5).
Percentages are related to the total genetic variance explained by the
genomic method (given in Table 2). The proportion of the genome
accounted for by each chromosome (PG) is also given.
Additional file 5: Percentage of genetic variance explained per
chromosome. Blue bars correspond to estimates analysing each
chromosome separately (Additional file 4), and red bars correspond to
estimates obtained through the joint chromosomal decomposition
(Additional file 3). Error estimates for the first method (dashed lines) were
obtained based on a Taylor series approximation. Lack of convergence of
the REML analyses for the second method meant that the variance/
covariance matrix, and thus the errors, could not be estimated.
Additional file 6: Regional heritability analysis. P-values for the
significance of the genetic variance explained by each window of 20
SNPs for all traits, considering a Bonferroni-corrected threshold (red line).
Additional file 7: Percentage of genetic variance explained for all
significant SNPs. Contains the percentage of genetic variance explained
by all significant SNPs (% VG SNPs) or by the regions of 20 SNPs centered
at the significant SNPs (% VG Regions).
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